Bearish flow noted in Relmada Therapeutics with 1,112 puts trading, or 1.3x expected. Most active are Nov-22 7.5 puts and Nov-22 5 puts, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 32.71, while ATM IV is up over 38 points on the day. Earnings are expected on November 10th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RLMD:
- Rising High: Exclusive talk with financial services firm Safe Harbor
- Here’s What You Missed in Cannabis This Week
- Point72 Asset Management reports 7.3% passive stake in Relmada Therapeutics
- Axsome shares could react positively to Relmada trial failure, says BofA
- Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs